Provided by Tiger Trade Technology Pte. Ltd.

Guardant Health Inc.

170.69
+2.811.67%
Post-market: 170.65-0.0400-0.02%19:30 EDT
Volume:1.92M
Turnover:324.20M
Market Cap:22.91B
PE:-48.72
High:170.85
Open:167.25
Low:165.01
Close:167.88
52wk High:176.58
52wk Low:53.40
Shares:134.20M
Float Shares:129.78M
Volume Ratio:0.71
T/O Rate:1.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5037
EPS(LYR):-3.3203
ROE:-4584.47%
ROA:-18.07%
PB:-102.78
PE(LYR):-51.41

Loading ...

Movement Alert|Guardant Health Inc. Rises 5.03% in Regular Trading, Trading at $171.23

Market Focus
·
Aug 21

Soccer-Sheffield United's Ex-Owners Winds up Company Which Bought Club

Reuters
·
Aug 19

Guardant Health Director Tariq Musa Disposes of 116 Common Shares Worth $18,148.2

Reuters
·
Aug 19

Guardant Health (GH) Back In Focus As New Approvals Put Valuation To The Test

Simply Wall St.
·
Aug 18

Guardant Health Chief People Officer Terilyn Monroe Disposes of Common Shares Worth $7.61 Million

Reuters
·
Aug 14

Guardant Health Chief Commercial Officer Chris Freeman Disposes of $ 10.75 Million in Common Shares

Reuters
·
Aug 12

Guardant Health Grants 46,044 RSUs to 149 New Employees Under Inducement Plan

Reuters
·
Aug 11

Is GH Research’s Rising Loss Per Share Reframing the GHRS Cash Burn Narrative?

Simply Wall St.
·
Aug 10

Guardant Health (GH) Following Earnings And Higher Guidance Has Valuation Back In Focus

Simply Wall St.
·
Aug 08

RBC Capital Remains a Buy on GH Research (GHRS)

TIPRANKS
·
Aug 08

Analysts Have Conflicting Sentiments on These Healthcare Companies: InMode (INMD), GH Research (GHRS) and Scholar Rock Holding (SRRK)

TIPRANKS
·
Aug 08

Movement Alert|Guardant Health Inc. Rises 5.39% in Regular Trading, Q2 Revenue Beat and Full-Year Guidance Raise Extend Post-Earnings Momentum

Market Focus
·
Aug 07

GH Research is Maintained at Buy by Needham

Dow Jones
·
Aug 07

GH Research price target raised to $39 from $32 at Needham

TIPRANKS
·
Aug 07

GH Research reports Q2 EPS (23c), consensus (30c)

TIPRANKS
·
Aug 06

GH Research Q2 EPS $(0.23) Beats $(0.30) Estimate

Benzinga Earnings
·
Aug 06

Guardant Health Director Ian T. Clark Disposes of Common Shares Worth $2.25 Million

Reuters
·
Aug 06

Guardant Health is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Aug 04

Guardant Health (GH) Filed A Shelf Registration To Keep Future Funding Options Open

Simply Wall St.
·
Aug 04

Analysts Conflicted on These Healthcare Names: Guardant Health (GH) and Cardinal Health (CAH)

TIPRANKS
·
Aug 03